- Home
- VANI vs IROQ Comparison
VANI vs IROQ Comparison
Compare VANI & IROQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- IROQ
- Stock Information
- Founded
- VANI 1998
- IROQ 1883
- Country
- VANI United States
- IROQ United States
- Employees
- VANI N/A
- IROQ N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- IROQ Savings Institutions
- Sector
- VANI Health Care
- IROQ Finance
- Exchange
- VANI Nasdaq
- IROQ Nasdaq
- Market Cap
- VANI 81.2M
- IROQ 82.7M
- IPO Year
- VANI 2014
- IROQ 2011
- Fundamental
- Price
- VANI $1.40
- IROQ $26.00
- Analyst Decision
- VANI Strong Buy
- IROQ
- Analyst Count
- VANI 1
- IROQ 0
- Target Price
- VANI $4.00
- IROQ N/A
- AVG Volume (30 Days)
- VANI 435.3K
- IROQ 11.5K
- Earning Date
- VANI 11-13-2025
- IROQ 10-31-2025
- Dividend Yield
- VANI N/A
- IROQ 1.54%
- EPS Growth
- VANI N/A
- IROQ 154.92
- EPS
- VANI N/A
- IROQ 1.60
- Revenue
- VANI N/A
- IROQ $27,979,000.00
- Revenue This Year
- VANI N/A
- IROQ N/A
- Revenue Next Year
- VANI N/A
- IROQ N/A
- P/E Ratio
- VANI N/A
- IROQ $16.24
- Revenue Growth
- VANI N/A
- IROQ 24.68
- 52 Week Low
- VANI $0.91
- IROQ $21.00
- 52 Week High
- VANI $1.92
- IROQ $26.50
- Technical
- Relative Strength Index (RSI)
- VANI 44.06
- IROQ 58.08
- Support Level
- VANI $1.36
- IROQ $25.70
- Resistance Level
- VANI $1.50
- IROQ $26.14
- Average True Range (ATR)
- VANI 0.11
- IROQ 0.10
- MACD
- VANI -0.02
- IROQ 0.01
- Stochastic Oscillator
- VANI 13.52
- IROQ 69.57
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
About IROQ IF Bancorp Inc.
IF Bancorp Inc is a holding company mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company, in association, takes deposits from the general public and invests those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, etc., and offers a variety of deposit accounts and alternative delivery channels. In addition to the traditional banking products and services, the group also offers a full line of property and casualty insurance products, annuities, mutual funds, individual securities, managed accounts, and other financial services.